Greg Jensen - Aug 15, 2021 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role: Vice President, Finance & CFO
Signature: /s/ Amy Culbert, attorney-in-fact
Stock symbol: XTNT
Transactions as of: Aug 15, 2021
Transactions value $: $0
Form type: 4
Date filed: 8/17/2021, 04:20 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XTNT	Common Stock, $0.000001 par value	Award	$0	+156K	+121.05%	$0.00	285K	Aug 15, 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	XTNT	Stock Option (right to buy)	Award	$0	+192K		$0.00	192K	Aug 15, 2021	Common Stock	192K	$1.27	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares will vest and be issued with respect to 39,062 shares on each of August 15, 2022, August 15, 2023 and August 15, 2024 and with respect to 39,064 shares on August 15, 2025 pursuant to a restricted stock unit granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
F2	Includes 244,587 shares that will be issued over time subject to vesting pursuant to restricted stock units granted under the Xtant Medical Holdings, Inc. 2018 Equity Incentive Plan.
F3	This option vests with respect to 48,077 shares on August 15, 2021 and with respect to the remaining 75% of such shares over the three-year period thereafter in 12 as nearly equal as possible quarterly installments, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.